Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone

被引:31
作者
Alkhalaf, M
El-Mowafy, AM
机构
[1] Kuwait Univ, Fac Med, Dept Biochem, Safat 13110, Kuwait
[2] Kuwait Univ, Dept Appl Therapeut, Fac Pharm, Hlth Sci Ctr, Safat 13110, Kuwait
关键词
D O I
10.1677/joe.0.1790055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have recently shown that growth inhibition of breast cancer cells by progesterone is due to the induction of cell differentiation, but not apoptosis. Because the tumor suppressor protein p53 plays a central role in normal cell growth and in tumor suppression, we have examined the effect of progesterone on the levels of this protein in MCF-7 cells. We show here that the antiproliferative effect of progesterone is accompanied with down-regulation of endogenous p53 protein. To study the effect of progesterone on cell growth in the presence of normal levels of p53 protein, we used transient transfection to overexpress p53 protein. MCF-7 cells were transfected with a p53 expressing vector that contains p53 human cDNA under the control of a cytomegalovirus promoter. Cell growth, cell viability, and apoptosis were analyzed in the transfected cells after six days of exposure to 100 nM progesterone. We show here that progesterone significantly enhances growth inhibition and apoptosis in MCF-7 cells overexpressing p53, but not in cells transfected with the control vector. These data suggest that re-establishing p53 function in MCF-7 breast cancer cells renders them more sensitive to the growth inhibitory effect of progesterone.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 35 条
[1]   REGULATION OF C-JUN AND JUN-B BY PROGESTINS IN T-47D HUMAN BREAST-CANCER CELLS [J].
ALKHALAF, M ;
MURPHY, LC .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (10) :1625-1633
[2]   Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein [J].
Alkhalaf, M ;
El-Mowafy, A ;
Karam, S .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2002, 11 (05) :481-488
[3]   Non-transcriptional action of oestradiol and progestin triggers DNA synthesis [J].
Castoria, G ;
Barone, MV ;
Di Domenico, M ;
Bilancio, A ;
Ametrano, D ;
Migliaccio, A ;
Auricchio, F .
EMBO JOURNAL, 1999, 18 (09) :2500-2510
[4]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[5]   PROGESTIN REGULATION OF CELLULAR PROLIFERATION [J].
CLARKE, CL ;
SUTHERLAND, RL .
ENDOCRINE REVIEWS, 1990, 11 (02) :266-301
[6]  
FAN SJ, 1994, CANCER RES, V54, P5824
[7]  
Formby B, 1998, ANN CLIN LAB SCI, V28, P360
[8]   Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis [J].
Formby, B ;
Wiley, TS .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 202 (1-2) :53-61
[9]   Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells [J].
Goepfert, TM ;
McCarthy, M ;
Kittrell, FS ;
Stephens, C ;
Ullrich, RL ;
Brinkley, BR ;
Medina, D .
FASEB JOURNAL, 2000, 14 (14) :2221-2229
[10]   The molecular epidemiology of P53 gene mutations in human breast cancer [J].
Hartmann, A ;
Blaszyk, H ;
Kovach, JS ;
Sommer, SS .
TRENDS IN GENETICS, 1997, 13 (01) :27-33